Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease.
Andrea CarugnoNoemi BrigentiPaolo GisondiZeina Al GhadbanMichele PariettiPamela VezzoliPaolo SenaChiara PisciottaPublished in: The Australasian journal of dermatology (2023)